Home > Boards > US Listed > Medical - Drugs > Seelos Therapeutics Inc (SEEL)

Oh they dirty. They always been dirty.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
food4thought Member Profile
 
Followed By 11
Posts 1,580
Boards Moderated 0
Alias Born 10/11/07
160x600 placeholder
Seelos Therapeutics Announces Issuance of Composition of Matter Patent for SLS-007 PR Newswire (US) - 10/26/2020 9:00:00 AM
Seelos Therapeutics to Participate in Investor Conferences in November PR Newswire (US) - 10/22/2020 9:00:00 AM
Seelos Therapeutics Announces Sponsored Research Agreement with Duke University for Gene Therapy Studies of SLS-004 in Parkin... PR Newswire (US) - 9/23/2020 9:00:00 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 9/14/2020 4:03:08 PM
Seelos Announces Issuance of a New Patent and an Additional Notice of Allowance in Japan for Intranasal Racemic Ketamine (SLS... PR Newswire (US) - 9/14/2020 9:00:00 AM
Seelos Therapeutics Receives Notice of Allowance for an Additional US Patent for Trehalose (SLS-005) PR Newswire (US) - 9/10/2020 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2020 4:03:23 PM
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering PR Newswire (US) - 9/9/2020 2:00:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/8/2020 4:44:15 PM
Seelos Therapeutics Announces Pricing of $7.0 Million Registered Direct Offering PR Newswire (US) - 9/4/2020 9:08:00 AM
Seelos Therapeutics to Participate in the Cantor Virtual Global Healthcare Conference PR Newswire (US) - 8/28/2020 8:00:00 AM
Seelos Therapeutics Receives European Orphan Drug Designation for SLS-005 (Trehalose) in Sanfilippo Syndrome PR Newswire (US) - 8/25/2020 11:00:00 AM
Seelos Therapeutics Receives FDA May Proceed Notice to Initiate a Phase IIb/III Trial of SLS-005 in Amyotrophic Lateral Scler... PR Newswire (US) - 8/10/2020 9:15:00 AM
Seelos Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for SLS-005 (Trehalose) in Sanfilippo Syndrome PR Newswire (US) - 7/21/2020 9:00:00 AM
Seelos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire (US) - 7/16/2020 4:31:00 PM
Seelos Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire (US) - 7/16/2020 4:30:00 PM
Seelos Therapeutics Announces Initiation of Preclinical Study of SLS-007 in Parkinson's Disease PR Newswire (US) - 6/25/2020 8:00:00 AM
Seelos Therapeutics Announces Final Data from Phase I PK/PD Study of Intranasal Racemic Ketamine (SLS-002) and Clinical Devel... GlobeNewswire Inc. - 6/23/2020 7:00:10 AM
Seelos Therapeutics to Host Key Opinion Leader Call to Discuss Phase I Data and Upcoming Trial Design for SLS-002 GlobeNewswire Inc. - 6/15/2020 8:01:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 4:16:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2020 9:01:28 AM
Seelos Therapeutics Announces Initiation of Preclinical Study of SLS-004 in Parkinson’s Disease GlobeNewswire Inc. - 5/28/2020 7:01:10 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/21/2020 4:17:19 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 5/21/2020 6:02:00 AM
Seelos Therapeutics to Host Key Opinion Leader Call to Discuss the Unmet Medical Needs in Suicide and Depression GlobeNewswire Inc. - 5/19/2020 9:01:10 AM
food4thought   Friday, 09/04/20 11:19:18 AM
Re: None
Post # of 30032 
Oh they dirty. They always been dirty.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences